While a number of different prime/boost combination of vectors expressing malaria antigens have shown activation of CD8+ T cell responses and different degrees of protection against murine malaria [9], [27], [28] there are several advantages in the use of PPV-VLPs and MVA vectors expressing the CS antigen for T cell activation. This evidence concerns the gene CS and malaria.